Semnur Pharmaceuticals, Inc. (SMNR)

Semnur Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	0.04	0.02	0.01	0.01	0.03
Cash & Short-Term Investments	0.04	0.02	0.01	0.01	0.03
Cash Growth	-29.09%	66.67%	0%	-57.14%	-
Prepaid Expenses	1.1	0.58	0	0	0.05
Other Current Assets	0.05	-	5.98	-	-
Total Current Assets	1.19	0.6	6	0.01	0.07
Property, Plant & Equipment	0.75	0.75	0.69	0.69	0.69
Total Assets	1.94	1.35	6.68	0.7	0.76

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	6.92	5.91	-	-	-
Accrued Expenses	1.65	0.74	0.04	0.9	0.17
Short-Term Debt	2.11	3.52	-	-	-
Other Current Liabilities	-	-	-	-	0.02
Total Current Liabilities	10.67	10.17	0.04	0.9	0.2
Long-Term Debt	20.94	11.93	49.43	37.9	35.4
Total Liabilities	31.62	22.1	49.47	38.8	35.6

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	0.02	0.02	0.02	0	0
Additional Paid-In Capital	255.03	255.03	72.58	72.6	72.6
Retained Earnings	-284.72	-275.8	-115.38	-110.69	-107.43
Total Common Equity	-29.67	-20.75	-42.78	-38.09	-34.83
Shareholders' Equity	-29.67	-20.75	-42.78	-38.09	-34.83
Total Liabilities & Equity	1.94	1.35	6.68	0.7	0.76

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	23.05	15.45	49.43	37.9	35.4
Net Cash (Debt)	-23.01	-15.43	-49.42	-37.89	-35.37
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.10	-0.08	-0.25	-0.24	-0.22
Filing Date Shares Outstanding	230.21	230.21	160	160	160
Total Common Shares Outstanding	230.21	230.21	160	160	160
Working Capital	-9.48	-9.57	5.96	-0.88	-0.12
Book Value Per Share	-0.13	-0.09	-0.27	-0.24	-0.22
Tangible Book Value	-29.67	-20.75	-42.78	-38.09	-34.83
Tangible Book Value Per Share	-0.13	-0.09	-0.27	-0.24	-0.22
Machinery	-	0.03	0.03	0.03	0.03
Construction In Progress	-	0.75	0.69	0.69	0.69

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error